ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

NGM Biopharmaceuticals, Inc clinical trials

Part of Atlas Neon Parent, Inc., which holds 100% as of 2024-04-05. Source

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 26 studies whose lead sponsor is NGM Biopharmaceuticals, Inc. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 6, 2026.

Our grouping of 1 registry name, not the registry’s. See them and correct one ↓

Compare NGM Biopharmaceuticals with Sino Biopharmaceutical and Bristol-Myers Squibb →

Pipeline: 2 programs

Each counted once: 2 with a study NGM Biopharmaceuticals, Inc leads registered in the last two years.

  • Phase 2

The 2 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of NGM Biopharmaceuticals, Inc’s own registered studies; NGM Biopharmaceuticals, Inc’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs NGM Biopharmaceuticals, Inc’s studies test, most open studies first — 3 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

1 of NGM Biopharmaceuticals, Inc’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. J
  9. J
  10. A
  11. S
  12. O
  13. N

Add it to your calendar (.ics) → With an account.

All 26 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now14%
  • Under way, not recruiting312%
  • Completed1973%
  • Stopped early312%Withdrawn 2 · Terminated 1

Phase

  • Phase 115
  • Phase 215
  • Phase 31

Where

  • United States18
  • Australia10
  • Puerto Rico3
  • France2
  • United Kingdom2
  • New Zealand2

Over the years

  1. 13
  2. 14
  3. 15
  4. 16
  5. 17
  6. 18
  7. 419
  8. 20
  9. 21
  10. 22
  11. 23
  12. 24
  13. 25
  14. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to NGM Biopharmaceuticals, Inc.

  • NGM Biopharmaceuticals, Inc
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    26 studies

Studies

Recruiting first, then most recently updated. Showing 26 of 26.